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Abstract: Genome-wide association studies have been successful in uncovering novel genetic variants that 
are associated with disease status or cross-sectional phenotypic traits. Researchers are beginning to inves-
tigate how genes play a role in the development of a trait over time. Linear mixed effects models (LMM) are 
commonly used to model longitudinal data; however, it is unclear if the failure to meet the models distri-
butional assumptions will affect the conclusions when conducting a genome-wide association study. In an 
extensive simulation study, we compare coverage probabilities, bias, type 1 error rates and statistical power 
when the error of the LMM is either heteroscedastic or has a non-Gaussian distribution. We conclude that the 
model is robust to misspecification if the same function of age is included in the fixed and random effects. 
However, type 1 error of the genetic effect over time is inflated, regardless of the model misspecification, if 
the polynomial function for age in the fixed and random effects differs. In situations where the model will not 
converge with a high order polynomial function in the random effects, a reduced function can be used but a 
robust standard error needs to be calculated to avoid inflation of the type 1 error. As an illustration, a LMM 
was applied to longitudinal body mass index (BMI) data over childhood in the ALSPAC cohort; the results 
emphasised the need for the robust standard error to ensure correct inference of associations of longitudinal 
BMI with chromosome 16 single nucleotide polymorphisms.
Keywords: ALSPAC; genome-wide association; longitudinal studies; misspecificiation; mixed model; 
robustness.
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1  Introduction
Over recent years, the study of population genetics has progressed from candidate gene and linkage studies 
over relatively small regions of the genome to whole genome association analyses. These genome-wide asso-
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ciation studies (GWAS) are designed to search the entire genome for single nucleotide polymorphisms (SNPs) 
that are associated with a disease or trait of interest. If SNPs are found to be associated, they are then con-
sidered to mark a region of the genome that influences the risk of disease or affects the levels of a trait. In 
general, very small effects are detected so large sample sizes are required. This advance in the scale of genetic 
analyses has transformed the field from hypothesis driven research to a hypothesis free approach, which 
has required additional statistical methods to be developed to ensure there is a balance between acceptable 
levels of power and the chance of inflating the type 1 error. Given the cost of conducting these studies, in 
terms of both monetary costs for genotyping samples and computational costs for the analysis, it is important 
that appropriate analyses are conducted from the outset.
To date, most of the GWAS have focused on case/control studies of particular diseases or cross-sectional 
measurements of phenotypic traits. These study designs typically use relatively simple statistical techniques, 
such as χ2 tests or linear (or logistic) regression models, to look at the association between a trait and each 
of the ∼2.5 million SNPs. There are now over 1500 published studies focusing on 250 traits using analyses of 
this kind (Hindorff et al., 2010). However, researchers are beginning to focus on more complex analyses to 
uncover additional genetic loci and reduce the currently unexplained heritability of these traits. One area of 
extension is to use longitudinal studies, with repeated measures on each individual in the study, to under-
stand how SNPs affect changes over time of a particular phenotype (Kerner et al., 2009; Smith et al., 2010; 
Sikorska et al., 2013). There are several developed statistical methods commonly used for repeated measures 
data to take into account the non-independence of measurements within an individual. For continuous traits, 
the most popular statistical method is the linear mixed effects model (LMM) by Laird and Ware (Laird and 
Ware, 1982). This method can be computationally intensive as the model can account for linear or non-linear 
trajectories for the outcome of interest over time, correlation between measures at the starting point (inter-
cept) and change over time (slope, or non-linear trajectory) within an individual and adjustment for both 
time-independent and time-dependent covariates.
In LMMs, the usual assumptions made about the random effects and error distributions include: 
the random effects and error terms are normally distributed, the random effects are independent of the 
error term and the error term has homoscedastic variance (Laird and Ware, 1982). In studies utilizing this 
method to assess the association of a SNP with the trajectory, the fixed effect estimates are often of most 
interest; the random effects and correlation structure at the individual level are necessary to provide an 
accurate fit of the model to the data, in addition to providing appropriate test statistics, but are treated as 
nuisance parameters and are often difficult to interpret. There have been a number of studies investigat-
ing whether violations of the assumptions about the random effects and error terms affect the maximum 
likelihood inference of the fixed effect parameters and their variance estimates; several manuscripts have 
shown that the fixed effects estimates are robust to non-Gaussian random effects distribution (Verbeke and 
Lesaffre, 1997; Zhang and Davidian, 2001), non-Gaussian or heteroscedastic error distribution (Jacqmin-
Gadda et al., 2007) and that the population fixed effects are robust to misspecified covariance structure 
(Taylor et al., 1994), but the individual level predictions are not (Taylor and Law, 1998). Jacqmin-Gadda 
et al. (2007) show the fixed effects estimates are not robust to error variance that is dependent on a covari-
ate in the model that interacts with time. Liang and Zeger (1986) demonstrated that a robust sandwich 
estimator (Royall, 1986) can correct for biased variance estimates of the fixed effects when the covariance 
structure is not correctly specified. There has not been any investigation, to our knowledge, into how any 
of these model misspecifications affect the power and type 1 error in high dimensional studies, for example 
when running an LMM on a genome-wide scale, and what the value of the robust variance estimator is in 
this context.
The aim of this study is to assess by simulations whether misspecification of the error term, with either 
non-Gaussian error distributions or non-constant error variance, in a complex longitudinal model with non-
linear trajectories will affect: 1) the coverage probabilities of the 95% confidence interval of the fixed effects 
parameter estimates; 2) the bias of the fixed effects parameter estimates; 3) the type 1 error of SNP detection 
in a GWAS; or 4) the statistical power to detect association. We also examined whether our conclusions differ 
according to minor allele frequency (MAF) for the SNPs or sample size of the investigated cohort.
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2  Motivating example
The World Health Organization defines obesity as “abnormal or excessive fat accumulation that presents a 
risk to health” (World Health Organization, 2012). Obesity is a medical condition which increases an individ-
ual’s risk to health problems such as cardiovascular disease, type 2 diabetes and some cancers and therefore 
reduces life expectancy (Haslam and James, 2005). The prevalence of obesity has been increasing in recent 
decades in developed countries, particularly in children. Body mass index [BMI; calculated as weight (kg)/
height2 (m)] is commonly used to define overweight and obesity, with appropriate cut-offs defined for both 
children (Cole et al., 2000) and adults (WHO, 2000). Childhood obesity is one of the strongest predictors 
of adult obesity (Serdula et al., 1993; Kindblom et al., 2009). Although the growing prevalence of obesity is 
most likely to be due to the increasing energy intake and decreasing energy expenditure, twin and adoption 
studies have provided evidence that BMI is heritable (Maes et al., 1997; Parsons et al., 1999; Haworth et al., 
2008; Wardle et al., 2008). Recent GWAS have begun to uncover some plausible genetic loci contributing to 
higher BMI (Fox et al., 2007; Frayling et al., 2007; Loos et al., 2008; Thorleifsson et al., 2009; Willer et al., 
2009; Liu et al., 2010; Speliotes et al., 2010) and obesity in children (Bradfield et al., 2012), with 34 new loci 
identified. However, none of the studies to date provide information regarding the genetic determinants of 
the rate of BMI growth over childhood, which leads to obesity.
The Avon Longitudinal Study of Parents and Children (ALSPAC) (Boyd et al., 2013; Fraser et al., 2013) 
is a birth cohort study; 14,541 pregnant women in the former county of Avon, UK, were recruited into the 
study if they had an expected delivery date between 1st April 1991 and 31st December 1992. From birth to 5 
years, length and weight measurements were extracted from health visitor records, with up to four measure-
ments taken on average at six weeks, 10, 21, and 48 months of age. For a random 10% of the cohort, length 
and height measurements were taken in eight research clinic visits held between the ages of 4 months and 
5 years of age. From age 7 years upwards, all children were invited to annual research clinics from ages 7 to 
11 and biannual research clinics thereafter. Details of measuring equipment used in the clinics is described 
elsewhere (Howe et al., 2010). In addition, parent-reported child height and weight were also available from 
questionnaires (27% of measurements). Whilst the measurements from routine health care have previously 
been shown to be accurate in this cohort (Howe et al., 2009), parental report of children’s height tends to be 
overestimated while weight tends to be under estimated (Dubois and Girad, 2007). Ethical approval for the 
study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. 
Please note that the study website contains details of all the data that is available through a fully searchable 
data dictionary (http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/).
A subset of 7916 participants were used for analysis based on the following inclusion criteria: at least 
one parent of European descent, singleton birth, unrelated to anyone in the sample, genome-wide genotype 
data, and at least one measure of BMI throughout childhood. Participants have a median of 9 BMI measure-
ments between 1 and 15 years of age (interquartile range 5–12, range 1–29 measurements). Children tend to 
have rapidly increasing BMI from birth to approximately 9 months of age where they reach their adiposity 
peak; BMI then decreases until around the age of 5–7 years at adiposity rebound and then steadily increases 
again until after puberty where it tends to plateau through adulthood. There is a large amount of variability 
between individuals for both intercept and slope.
The primary research question is to identify SNPs that are associated with average BMI and change in BMI 
over childhood and adolescence in the ALSPAC data. A LMM was used to appropriately model the longitudinal 
trajectory over childhood, to account for the large correlation between each of the random effects parameters, 
to adjust for additional covariates such as the source of the height/weight measurements (clinic or question-
naire) and to allow data to be missing at random across childhood. The general form of the model is as follows:
 i i i i iY X Z bβ ε= + +  (1)
where Yi is the response vector for the ith individual, β is the vector of fixed effects and bi∼N(0, Σ) is the vector 
of subject specific random effects, Xi and Zi are the fixed effect and random effect regressor matrices respec-
tively and εi∼N(0, σ2) is the within subject error vector. When applying this model to the ALSPAC data, the 
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best model fit included a cubic polynomial of mean centred age (centred at age 8 years) in the fixed effects, a 
quadratic polynomial of mean centred age in the random effects and a continuous autoregressive correlation 
structure of order one for the covariance of the within-subject errors. Hence, the final model for both females 
and males was:
 
2 3
ij 0 1 ij 2 ij 3 ij 4 ij 5 i 6 ij i
2 3 2
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(2)
where MS is the measurement source (i.e., clinical visit or questionnaire) of individual i at time j and tij is the 
age (centred at 8). Therefore β0 is the population intercept (i.e., mean BMI at age 8), β1–β3 are the fixed effects 
for the cubic function of age, β4 is the measurement source, β5 is the change in the mean BMI at 8 years of 
age for each additional copy of the minor allele, β6 is the SNP by linear age effect, β7 and β8 are the SNP by 
quadratic and cubic effects respectively.
Due to the nature of the data collection, which is often complex in large cohort based studies, we found 
that the model assumptions were not met due to the following:
1. The questionnaire measures have previously been shown to have greater variability than clinic measured 
height and weight (Dubois and Girad, 2007); therefore we had variability that was dependent on a covari-
ate in the model.
2. There were only questionnaire measures available around the nadir of the trajectory (also known as the 
adiposity rebound), which meant we had greater variability around the rebound.
3. The variability within individuals changes over time; particularly with increased variability around 
puberty and into adolescence.
4. BMI also has a non-Gaussian error distribution. This is in part due to the increasing variability between 
individuals over time, with some individuals having rapidly increasing BMI while others remain rela-
tively consistent.
In the following, we investigate the robustness of the maximum likelihood inference for the fixed effects, the 
type 1 error and the power for detecting an association with the SNP when the error distribution is misspeci-
fied due to the above intricacies of the data.
3  Simulation study
We carried out extensive simulations to investigate the effects on the LMM when the error term (also called 
the level-1 residual, or the occasion-level residual) in the model was non-Gaussian or had a non-constant 
variance. In each of the simulation scenarios, we set the non-genetic fixed effects parameters [β0–β4 from 
model (2)] and the variance-covariance matrix similar to those coming from the fitted model for BMI adjust-
ing for the FTO rs1121980 SNP in the ALSPAC study; these can be found in Table 1. The measurement source, 
which is a fixed effect in the LMM and used in the heteroscedastic error simulations, was a randomly gener-
ated binary variable for each individual at each time point with distribution throughout the ages similar to 
the distribution in the ALSPAC cohort (percent questionnaire measurements per follow-up year: year 1 = 40%, 
year 2 = 20%, year 3 = 40%, year 4 = 10%, year 5 = 60%, year 6 = 99%, year 7 = 10%, year 8 = 0%, year 9 = 0%, year 
10 = 10%, year 11 = 0%, year 12 = 0%, year 13 = 30%, year 14 = 0%, year 15 = 0%).
We also investigated the fixed effect estimation for various sample sizes, minor allele frequencies of the 
SNP and the SNP effect sizes:
1. Sample size: two levels; n = 1000 and n = 3000
2. Minor allele frequency: four levels; 0.1, 0.2, 0.3 and 0.4
3. Effect sizes: two combinations; β5 = 0.6, β6 = 0.15, β7 = –0.000752 and β8 = –0.000380 (alternative hypothesis) 
or β5 = β6 = β7 = β8 = 0 (null hypothesis). The alternative hypothesis effect sizes for β5 and β6 were chosen to 
have 80% power to detect with the larger sample size; the effect sizes for β7 and β8 were similar to those 
coming from the fitted model for BMI adjusting for the FTO rs1121980 SNP in the ALSPAC study.
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3.1  Sampling designs
As many longitudinal cohorts have different sampling designs, some with variable amounts of missing time 
points and missing observations at each time point, we investigated five different sampling designs:
1. Sparse complete: ni = 8 measures per person with few measures around the adiposity rebound; times of 
measures are 1, 2, 3, 5, 8, 10, 13, 15
2. Intense complete: ni = 14 measures per person with multiple measures around the adiposity rebound; 
times of measures are 1, 2, 3, 3.5, 4, 4.5, 5, 5.5, 6, 7, 9, 11, 13, 15
3. Equal unbalanced: ni = 1–15 measures per person between 1 and 15 years with a mean of 9 measures (pro-
portion of missingness = 0.4 across whole age range)
4. Unbalanced with more samples around the adiposity rebound: ni = 1–15 measures per person between 1 
and 15 years with a mean of 9 measures; proportion of missingness around adiposity rebound of 0.2 and 
0.45 outside the 5–7 year age range (average proportion of missingness over whole age range is 0.4)
5. Unbalanced with fewer samples around the adiposity rebound: ni = 1–15 measures per person between 1 
and 15 years with a mean of 9 measures; proportion of missingness around adiposity rebound of 0.6 and 
0.35 outside the 5–7 year age range (average proportion of missingness over whole age range is 0.4)
The first two designs with complete data at each follow-up assume that every individual had the exact same 
age at follow-up (i.e., came into clinic on their birthday), whereas the other three designs are more repre-
sentative of longitudinal studies where the actual age of measurement varies between individuals by up to a 
year (i.e., came into clinic either 6 months before or after a birthday). We assume data is missing completely 
at random, that is that the probability that an observation is missing for a given individual is independent 
of all other observed data. The proportion of missingness simulated across the whole range (i.e., 0.4) was 
equivalent to the amount of missing data observed in the ALSPAC cohort under the assumption that all indi-
viduals could have been measured yearly. We used a fully factorial design for the simulations with the 3 data 
characteristics and the 5 sampling designs.
3.2  Models for data generation
Standard linear mixed model:
Data were generated with Gaussian random effects and error distribution to validate the estimation method.
Non Gaussian error:
Three error structures were investigated:
Table 1 Parameter estimates from the ALSPAC non-genetic model used to generate the data in the simulation study.
Effect   Parameter  Value
Intercept   β0   16.534
Age   β1   0.400
Age2   β2   0.056
Age3   β3   –0.003
Source   β4   –0.153
SD(b0)   σ0   2.092
SD(b1)   σ1   0.269
SD(b2)   σ2   0.0235
Cor(b0, b1)   ρ0   0.820
Cor(b0, b2)   ρ1   –0.389
Cor(b1, b2)   ρ2   –0.092
SD(ε)   σ   1.063
Correlation structure  ρ   0.394
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1. t-distribution: t with 5 degrees of freedom
2. skew-normal distribution: SN(1.0632, 40)
3. Asymmetric mixture of two Gaussian distributions: 0.3N(–0.67, 12)+0.7N(0.5, 0.32)
Heteroscedastic error:
Three cases were studied:
1. Variance dependent on a covariate: 2ij e ijVar(e )= aXσ
 where 2e 1.131,σ =  a = 1.500 and Xij = 1 if measure was from questionnaire and 0 if measure was from a fol-
low-up clinic
2. Variance greater at the adiposity rebound: 2ij e ijVar(e )= aXσ
where 2e 1.131,σ =  a = 1.500 and Xij = 1 if measure was between 5 and 7 years and 0 if not
3. Variance increasing over time: ijt2ij eVar(e )= aσ
where 2e 1.131σ =  and a = 1.150
3.3  Data generation
We simulated 1000 datasets under the alternative hypothesis (β5 = 0.6 and β6 = 0.15) to look at coverage prob-
abilities, bias and power and 5000 datasets under the null hypothesis (β5 = 0 and β6 = 0) to look at type 1 error 
at α = 0.05. Each SNP (coded as 0, 1, 2) was incorporated into the model assuming an additive genetic model, 
whereby each additional minor allele increases BMI by an equal amount. We were primarily interested in 
estimating the SNP main effect, β5, which represents the increase on the mean BMI at 8 years of age for each 
additional copy of the minor allele and the SNP by age effect, β6 (referred to as the SNP*age interaction), 
which represents the effect on the mean linear increase of BMI (slope) for each additional minor allele. We 
calculated a robust standard error for each fixed effect parameter and corresponding p-value; the following 
formula was used:
     
1
( ) ( )
S
i ii ii i
i=
 
′′ ′ ′  ∑
-1 -1 -1 -1
-1 -1X V X X V V X X V Xε ε
Where:
X is the fixed effect regressor matrix from equation (1)
V  is the estimated variance of Y from equation (1)
i i iyε β= −X
S is the number of subjects and i is the ith subject
In addition to the fixed effects parameters, we applied a Wald test to assess whether the overall SNP 
effect was affected by the misspecification. The Wald test was estimated using the General Linear Hypoth-
esis approach (McDonald, 1975). This approach is based on the normal approximation for maximum likeli-
hood estimators using the estimated variance-covariance matrix. The hypothesis can be specified through a 
constant matrix L to be matched with the fixed effects of the model such that H0: Lβ = m where the m are the 
hypothesized values. The estimates of the fixed effects, β, asymptotically follow a multivariate normal distri-
bution  ( , cov( ))Nβ β β∼  by the Central Limit Theorem such that the linear form also asymptotically follows 
a multivariate normal distribution:
 
 ~ ( , cov( ) )L N L L Lβ β β ′  
(3)
Thus the 95% confidence interval and corresponding P-value for the hypothesized value can be obtained 
accordingly. We tested whether the parameters for the SNP were simultaneously equal to zero. It is compu-
tationally intensive to calculate a robust estimate for the Wald test; for example, the robust standard error 
for the fixed effects takes approximately 7 min for the rs1121980 FTO SNP in the ALSPAC data whereas the 
robust standard error for the global Wald test takes approximately an additional 3 min. These computational 
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times decrease exponentially as sample size and the number of repeated measures per individual decreases; 
however, they may not be scalable to a GWAS study. To investigate whether a robust standard error would be 
beneficial for the global Wald test, we selected the scenario where the inflation was greatest and calculated 
the robust estimates for all the simulations in this scenario. All analyses were conducted in R version 2.12.1 
(Ihaka and Gentleman, 1996) using the nlme package.
As it is important to report the uncertainty in any estimates from simulation based studies (Koehler et al., 
2009), Monte Carlo error (MCE) was calculated using the joint performance method of β  and si outlined in 
White (2010). A confidence interval for coverage probabilities, bias, type 1 error and power was calculated 
using the following:
 
 P(1-P)P 1.96
S
 
±     
(4)
Where P is the α-level, for example P for coverage estimates is 0.95 and P for type 1 error is 0.05, and S is the 
number of simulations, for example either 1000 or 5000. The output from the simulations was then assessed 
as to whether they fell within this confidence interval.
3.4  Results
3.4.1  Coverage probabilities
Coverage probability can indicate whether the confidence interval of the parameter(s) of interest is conserva-
tive (i.e., the coverage probability is larger than the nominal confidence interval) or liberal (i.e., the coverage 
probability is narrower than the nominal confidence interval).
Coverage probabilities for the 95% confidence interval of the fixed effects parameter estimates from each 
of the simulations are presented in Table 2. No consistent differences were seen across the range of minor allele 
frequencies, so the results from each of the simulated datasets were combined for ease of presentation; however 
the coverage probabilities for each of the minor allele frequencies are presented in Supplementary Table 1.
The coverage probabilities of the SNP main effects parameter for all simulations appear to be unaffected 
by the error misspecifications; only nine of 70 coverage probabilities were significantly different from 95%, 
that is less than 94.32% or greater than 95.68%, five of which were from the simulations where the error vari-
ance increases over time.
Thirty-one of the 70 coverage probabilities (44%) for the SNP*age interaction parameter were signifi-
cantly different from 95%, with both the non-Gaussian and heteroscedastic error distributions being affected. 
When the error variance followed a t distribution, the coverage probabilities for the confidence interval of the 
SNP*age interaction parameter are  < 95% in all designs except the sparse complete scenario. Similarly, the 
SNP*age interaction parameter had coverage probabilities  < 95% when the error variance followed a skew-
normal distribution, however only in the unbalanced designs where there is missing data. The coverage prob-
abilities were  < 95% when the error variance was both dependent on a covariate and increased over time, in 
both the complete and unbalanced designs. All the coverage probabilities that significantly differ from 95% 
for the SNP*age interaction parameter have underestimated variance estimates and thus confidence intervals 
that were too narrow, which could lead to test statistics that are too liberal.
3.4.2  Bias
The SNP main effect and the SNP*age interaction parameters are unbiased in the majority of the simulations, 
indicating that the misspecifications in the error distribution do not affect the estimates of the β’s (Supplemen-
tary Tables 2 and 3). Only nine of 140 95% confidence intervals did not cover zero; these nine confidence intervals 
were across the range of error distributions and designs, showing that no one scenario was particularly biased.
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Table 2 Coverage rates of the 95% confidence intervals of the fixed effects; bold and underlined cells are those that are signifi-
cantly different from the nominal 95% based on 4000 simulations under each design (1000 simulations for each MAF combined 
into one summary statistic).
Sampling 
design
Unbalanced with more 
samples around the 
adiposity rebound
 
 
Unbalanced with less 
samples around the 
adiposity reboundSparse complete Intense complete Equal unbalanced
Sample size n = 1000  n = 3000 n = 1000  n = 3000 n = 1000  n = 3000 n = 1000  n = 3000 n = 1000  n = 3000
Gaussian Distribution
 SNP   95.43  95.03  95.08  95.45  94.83  95.23  95.08  94.70  95.40  94.73
 SNP*age   95.00  95.23  94.58  95.13  94.35  94.63  94.30  93.90  94.53  94.35
t-distribution
 SNP   95.45  95.35  95.90  94.55  95.13  94.85  94.65  94.48  95.48  94.95
 SNP*age   95.30  94.80  94.05  94.13  94.45  94.10  93.70  94.00  93.33  94.03
Skew-normal Distribution
 SNP   94.90  95.03  95.18  95.10  95.05  94.25  95.43  94.95  94.85  94.75
 SNP*age   95.68  95.18  94.63  94.65  93.88  93.73  94.73  94.13  93.90  93.55
Mixture of 2 Gaussian Distributions
 SNP   94.85  94.98  94.83  95.65  95.00  95.08  94.53  95.40  94.33  94.48
 SNP*age   95.05  94.78  95.03  94.60  95.20  94.08  94.58  95.20  94.80  94.10
Variance dependent on a covariate
 SNP   94.93  95.05  95.83  95.35  94.43  94.75  94.70  94.93  94.98  94.93
 SNP*age   94.93  95.03  94.95  94.15  94.03  94.10  93.75  94.53  93.95  93.93
Variance greater at adiposity rebound
 SNP   94.75  95.23  95.15  95.08  94.25  95.20  95.48  95.35  95.23  94.43
 SNP*age   94.05  94.45  95.38  95.38  94.13  94.43  94.00  94.75  94.73  94.60
Variance increasing over time
 SNP   94.20  95.00  94.08  94.38  94.80  94.33  94.30  94.03  95.98  95.48
 SNP*age   94.10  94.88  91.78  92.38  94.70  94.23  93.28  93.48  95.65  95.25
No consistent differences were seen in the bias estimates across the range of minor allele frequencies; 
however, the 95% confidence intervals for the difference between the simulated parameter and the true 
parameter were tighter as the sample size and minor allele frequency increased (Supplementary Table 4).
3.4.3  Type 1 error
As seen with the coverage probabilities, no consistent differences in type 1 error were evident across the 
minor allele frequency range, so the results from each of the simulated datasets were combined for ease of 
presentation (Tables 3 and 4); however the type 1 error for each of the minor allele frequencies tested are 
given in Supplementary Table 5.
As seen in Table 3, the type 1 error for the complete designs remained within acceptable limits of the 
nominal alpha level. We observed inflation for the SNP by age interaction parameter in several cases, but this 
inflation was reduced to nominal levels by using a robust standard error.
Table 4 shows that the type 1 error for the SNP by age interaction was often inflated under the unbalanced 
designs. However, by using a robust standard error, the inflation seen can be reduced to nominal levels in 
the majority of cases; approximately 75% of the inflated effects were reduced. The design where the robust 
standard error didn’t seem to have an effect was when the error variance increased over time; only 20% of the 
estimates were reduced to nominal levels under this design. Interestingly, the robust standard error did not 
appear to affect the type 1 error for the scenarios that were not originally inflated.
To declare significance in a GWAS, several thresholds are commonly used: suggestive association, sig-
nificant association and highly significant association. Duggal et al. define suggestive associations as SNPs 
that reach a P-value threshold under the assumption that one false positive association is expected per GWAS 
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Table 3 Type 1 error for the complete designs; bold and underlined cells are those that are significantly different from the 
nominal α = 0.05 based on 20,000 simulations under each design (5000 simulations for each MAF combined into one summary 
statistic).
Sampling design   Sparse complete Intense complete
Sample size n = 1000   n = 3000 n = 1000 n = 3000
Standard  Robust Standard  Robust Standard  Robust Standard  Robust
Gaussian Distribution
 SNP   0.0514  0.0528  0.0509  0.0513  0.0502  0.0521  0.0500  0.0510
 SNP*age   0.0483  0.0504  0.0483  0.0491  0.0549  0.0486  0.0539  0.0467
 Global wald test   0.0497    0.0478    0.0605    0.0620 
t-distribution
 SNP   0.0495  0.0498  0.0489  0.0496  0.0479  0.0510  0.0483  0.0502
 SNP*age   0.0521  0.0534  0.0487  0.0492  0.0581  0.0490  0.0563  0.0465
 Global wald test   0.0531    0.0508    0.0624    0.0629 
Skew-normal Distribution
 SNP   0.0502  0.0517  0.0524  0.0524  0.0509  0.0526  0.0525  0.0532
 SNP*age   0.0503  0.0519  0.0461  0.0474  0.0541  0.0508  0.0529  0.0486
 Global wald test   0.0493    0.0488    0.0621    0.0579 
Mixture of 2 Gaussian Distributions
 SNP   0.0498  0.0504  0.0479  0.0479  0.0485  0.0499  0.0510  0.0508
 SNP*age   0.0502  0.0510  0.0492  0.0488  0.0528  0.0506  0.0529  0.0495
 Global wald test   0.0498    0.0508    0.0615    0.0586 
Variance dependent on a covariate
 SNP   0.0523  0.0527  0.0488  0.0490  0.0485  0.0511  0.0459  0.0485
 SNP*age   0.0546  0.0527  0.0531  0.0514  0.0520  0.0493  0.0524  0.0481
 Global wald test   0.0515    0.0525    0.0556    0.0546 
Variance greater at adiposity rebound
 SNP   0.0472  0.0478  0.0511  0.0519  0.0477  0.0493  0.0471  0.0490
 SNP*age   0.0528  0.0497  0.0570  0.0528  0.0513  0.0513  0.0491  0.0487
 Global wald test   0.0527    0.0540    0.0502    0.0478 
Variance increasing over time
 SNP   0.0523  0.0536  0.0471  0.0473  0.0543  0.0513  0.0561  0.0522
 SNP*age   0.0564  0.0538  0.0522  0.0491  0.0746  0.0528  0.0746  0.0530
 Global wald test   0.0875  0.0549  0.0875  0.0497  0.1667  0.0506  0.1685  0.0506
(Duggal et al., 2008); SNPs reaching this threshold are taken forward for replication. In the context of our 
simulation study, this definition would equate to a P-value of 0.00005 (1/20,000; where 20,000 is the number 
of simulations per design and error assumption). The scenario with the highest type 1 error inflation using the 
classical standard error was for the SNP*age interaction under the intense design where the error variance 
increased over time (0.0746 for both n = 1000 and 3000). In this scenario, 6 SNPs would falsely reach the defi-
nition of “suggestive association” for the SNP*age interaction parameter when using the classical standard 
error with a sample size of 1000 individuals. In contrast, when the model assumptions are met, that is when 
the error distribution follows a Gaussian distribution with constant variance, only 2 SNPs met the “sugges-
tive association” threshold, indicating an inflation in the type 1 error for the simulations where the variance 
increased over time due to the misspecification of the error term. When using the robust standard error under 
the increasing variance over time design, 1 SNP would meet the criteria, showing not only a reduction in the 
type 1 error from the 7 SNPs seen with the classical standard error, but also a reduction in power in compari-
son to the model where the assumptions were met.
These results show that there is greater inflation in the type 1 error for the SNP*age interaction in the 
unbalanced designs than the complete designs. As outlined in Supplementary Figure 1, we simulated addi-
tional data to investigate what aspects of the unbalanced design contributed to the inflation. Briefly, the 
results from these additional simulations are as follows:
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1. The unbalanced designs differed from the complete designs by including missing data and altering the 
measurement times so they fell within a range around the scheduled times, both of which are inher-
ent in cohort studies. The additional simulations showed the inflation was greater in the presence of 
missing data rather than because of the different measurement times between individuals (Supplemen-
tary Figure 2).
2. Since the LME is known to be robust to missing data under the missing at random and missing com-
pletely at random assumptions, we simulated additional data varying the polynomial function of age in 
the fixed and random effects. These simulations showed the type 1 error was reduced to nominal levels 
when the fixed and random effects had the same function of age, i.e., cubic function in both the fixed and 
random effects (Supplementary Table 6).
3. To determine whether there is remaining inflation in the type 1 error after modelling the same function of 
age in the fixed and random effects when the error distribution is misspecified we simulated additional 
data using the equal unbalanced sampling design. These simulations showed that the type 1 error was 
again reduced to nominal levels when the fixed and random effects had the same function of age regard-
less of the misspecification in the error distribution (Supplementary Table 7).
4. It is often difficult to estimate higher order terms in the random effects when using real data due to com-
putational and convergence issues. In this case, it is often only possible to fit a lower-order polynomial 
functions in the random effects than the fixed effects. We simulated additional data where the fixed and 
random effects included a quadratic function for age but we analyzed the data with a quadratic function 
in the fixed effects and a linear function in the random effects. In addition, we also simulated data where 
the fixed effects included a quadratic function for age and the random effects included only a linear 
function but analyzed the data with a quadratic function in both the fixed and random effects. These 
simulations showed that the type 1 error was inflated when the analysis model had lower order terms of 
polynomial function in the random effects compared to the fixed effects terms (Supplementary Table 8).
In summary, it is recommended that one includes the same polynomial function for age in the fixed and 
random effects to avoid inflation in the type 1 error; however, if this is not possible due to non-convergence of 
the model then a robust standard error is required to reach nominal levels of type 1 error.
The global Wald test, which is assessing whether there is any genetic effect on the whole BMI growth 
trajectory, was inflated above the acceptable limits under all error variance misspecifications and even under 
the Gaussian/constant variance assumption, except under the sparse complete design. The scenario where 
the error variance increased over time showed the largest inflation; however, using the robust estimates for 
the Wald test under this scenario were also reduced to nominal levels in most designs; if it wasn’t reduced to 
nominal levels it was dramatically lower than using the classical test (Table 4). Again, having the same struc-
ture of fixed and random terms for the age polynomial function would yield nominal type 1 errors.
Given that many researchers investigating GWAS of longitudinal traits are interested in only the SNP main 
effect and not the SNP*age interaction (Furlotte et al., 2012), we conducted some additional simulations without 
the SNP*age interaction. Once again, we used the scenario where the error variance increased over time and 
where there was equal unbalance in the data structure. We found that the type 1 error was within the nominal 
range for the SNP main effect for both sample sizes (n = 1000: 0.0506; n = 3000: 0.0515), where previously we saw 
inflation for the sample size of 1000 (0.0533 from Table 4). We have no reason to believe that any of the other 
scenarios would be affected by the misspecifications when the SNP*age interactions are not modelled.
3.4.4  Power
Effect sizes for the alternative hypothesis (β5 = 0.6 and β6 = 0.15) were chosen to have 80% power with a MAF of 
0.4 and sample size of 1000 when the error from the fitted LMM follows a Gaussian distribution with constant 
variance. Therefore, the power for all error distributions and MAFs in the simulations with sample size of 
3000 was greater than 80%; so this section will only discuss power for the simulations with a sample size of 
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Figure 1 Simulated power of the SNP main effect and SNP*age interaction terms for complete designs.
The two plots on the left are for the sparse complete design, while the two plots on the right are from the intense complete 
design. The solid black line for the Gaussian Distribution is the situation where the model is correctly specified.
1000. Power for the SNP main effect and SNP*age interaction parameters are displayed in Figures 1 (complete 
designs) and 2 (unbalanced designs).
As expected, the power increases with the MAF. Interestingly, assuming the error distribution has a t-distri-
bution led to lower power for both the SNP main effect and the SNP*age interaction parameters than assuming 
a Gaussian error distribution. This pattern was consistent across all of the sampling designs; however it appears 
that the power is slightly closer to that of the error with the Gaussian distribution when there is more data 
around the adiposity rebound (i.e., the intense complete and unbalanced with more samples around the adi-
posity rebound). In addition, the simulations where the error distribution follows a skew-normal distribution 
led to slightly higher power for both the SNP and SNP*age interaction parameters than with the Gaussian error.
When investigating the different error variance structures, the power for the SNP main effect parameter 
across all MAFs was slightly lower than the power when the constant variance assumption was met. Likewise, 
for the SNP*age interaction parameter, all of the error variance structures led to lower power than when the 
constant variance assumption was met. However, simulations under the unbalanced designs where the vari-
ance increased over time suffered the most and had notably reduced power until a MAF of approximately 0.3.
3.4.5  Power under the robust standard error
We have shown that using the robust standard error doesn’t affect those situations where the type 1 error 
wasn’t initially inflated, however before adopting the robust standard error for a GWAS analysis we also 
wanted to determine whether using the robust standard error would decrease our power to detect a statisti-
cally significant association.
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Figure 2 Simulated power of the SNP main effect and SNP*age interaction terms for unbalanced designs.
“Equal” is the simulations from the equal unbalanced design, “Over” are the simulations from the unbalanced design with less 
samples around the adiposity rebound and “Under” are the simulations from the unbalanced design with more samples around 
the adiposity rebound. The solid black line for the Gaussian Distribution is the situation where the model is correctly specified.
The power for the SNP main effect parameter remains almost unchanged when using the robust standard 
error rather than the normal standard error in all scenarios and under all model misspecifications (Figures 3 
and 4). The only scenario where the power decreased for the SNP main effect parameter by using the robust 
standard error was where there was increasing variance over time under the intense complete scenario. Given 
that the type 1 error was not inflated using either standard error estimate, there appears to be no harm in 
using a robust standard error for estimation even when not required.
The power for the SNP*age interaction parameter, particularly for low MAF, is much more variable. Under 
the sparse complete design, where there was no inflation in the type 1 error, the power remains about the same 
using either the classical or robust standard error. For the other designs, the power for the SNP*age interaction 
parameter decreases using the robust standard error, but only by 5% or less for most error misspecifications, 
when the MAF was 0.2 or greater. Assuming a t-distribution for the error led to a decrease of about 5–10% power 
using the robust standard error when the MAF 0.1 or 0.2; this might be due to the substantial reduction in type 
1 error. The power also decreases by greater than 5% when the variance is greater at the adiposity rebound and 
the variance is dependent on a covariate, for values of MAF around 0.1 in our scenarios.
4  Analysis of chromosome-wide body-mass-index data
Given our simulation results, in particular the need for a robust standard error to ensure accurate inference 
for the SNP*age interaction where the type 1 error is inflated, we wanted to investigate the impact of the dis-
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Figure 3 Difference in power based on a normal standard error vs. a robust standard error for the complete designs.
A positive value indicates the power using the normal standard error is greater than the power using the robust standard error. 
The two plots on the left are for the sparse complete design, while the two plots on the right are from the intense complete 
design. The solid black line for the Gaussian Distribution is the situation where the model is correctly specified.
tribution assumption problems in a real data application. GWAS analysis of multiple cohorts would be ideal 
to observe the effect of the different error term misspecifications; however this would require a large amount 
of computing time and was thus determined to be prohibitive. Instead, we chose to conduct analysis using 
chromosome 16 in the ALSPAC data as the most replicated gene for BMI to date, the fat mass and obesity 
gene (FTO), is located on this chromosome and we therefore hypothesised that we would detect some sig-
nificant loci on this chromosome as well as many non-associated SNPs. We used the same LMM model as in 
equation 2, with the inclusion of an age*sex interaction in the fixed effects for all the age components (i.e., 
2 3
9 i 10 ij i 11 ij i 10 ij isex + sex sex sext t tβ β β β+ + ) to account for the differences in growth between males and females 
(Warrington et  al., 2013). There were 14,875 SNPs genotyped on chromosome 16, all of which had a MAF 
greater than 1%; GWAS are designed to look at common SNPs, so it is a common strategy to exclude SNPs with 
MAF  < 1%. Each SNP was incorporated into the model assuming an additive genetic model.
As expected, SNPs in the FTO gene were highly significant for the global tests as well as the SNP main 
effect and SNP*age interactions. It is common to display GWAS analysis as a QQ plot of the observed –log10(P) 
with the expected –log10(P) under the null distribution. Figure 5 displays a QQ plot from the chromosome 16 
analysis in ALSPAC for each of the parameters which displayed inflated levels of type 1 error in the simulation 
study. As we believe SNPs within the FTO region to be true positives, we also display the QQ plots excluding 
SNPs from this region (Figure 5C and D). Lambda (λ) values are also commonly calculated for GWAS analyses, 
which is the ratio of the median of the empirically observed distribution of the test statistic to the expected 
median. The λ quantifies the extent of the excess false positive rate, with values close to 1 indicating no 
inflation and values deviating from 1 indicating increasing levels of false positives. The lambda values corre-
sponding to each QQ plot were calculated using the estlambda function in the GenABEL software (Aulchenko 
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Figure 4 Difference in power based on a normal standard error vs. a robust standard error for the unbalanced designs.
A positive value indicates the power using the normal standard error is greater than the power using the robust standard error. 
Here, “Equal” is the simulations from the equal unbalanced design, “Over” are the simulations from the unbalanced design 
with less samples around the adiposity rebound and “Under” are the simulations from the unbalanced design with more 
samples around the adiposity rebound. The solid black line for the Gaussian Distribution is the situation where the model is 
correctly specified.
et al., 2007); the “median” method was used with one degree of freedom for the fixed effects SNP terms and 
four degrees of freedom for the Wald test of the overall SNP effect. These QQ plots and lambda statistics 
clearly show that where the parameters have lambda values greater than one using the classical test, the 
robust test reduces this to nominal levels. When using the robust tests, we were still able to detect an associa-
tion with SNPs in the FTO gene.
In the chromosome wide analysis, the P-value to declare “suggestive significance” would be 0.000067 
(1/14,875). Using this threshold, 57 SNPs would reach suggestive significance for the SNP by age interaction 
using the classical standard error in comparison to only 16 SNPs using the robust standard error. Six of these 
16 SNPs were in the FTO gene, four of which would reach the significant threshold.
5  Discussion
In this article, we simulated longitudinal data that mimicked childhood BMI to explore the coverage prob-
ability, bias, type 1 error and power for association with a SNP when the linear mixed effects model is mis-
specified with either a non-Gaussian error distribution or heteroscedastic error. We have shown that the type 
1 error for the SNP*age interaction terms in a genetic association study has no inflation if the same function of 
age is included in both the fixed and random effects. However, type 1 error is inflated, regardless of the model 
misspecification, if the age function in the fixed and random effects differs. In situations where the model is 
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Figure 5 QQ plots of the chromosome 16 analysis in the ALSPAC cohort.
These plots are the observed –log10(P) against the expected –log10(P) under the null hypothesis for each SNP on chromosome 16. 
P-Values deviating from the dotted x = y line indicate significant findings, whether they be false (i.e., inflation in type 1 error) or 
true.
too complex and will not converge with a high order polynomial function in the random effects, an appro-
priate way to deflate the type 1 error to nominal levels is to use a robust standard error for the fixed effects 
parameters. Although robust standard errors have been previously used in a wide range of statistical applica-
tions, LMM’s are only just beginning to be utilized in GWAS and therefore guidance on their application was 
warranted. Given that QQ plots in GWAS are an important diagnostic to rule out the possibility of popula-
tion stratification, it is essential to generate standard errors that perform well under the null hypothesis so 
that any remaining inflation is not due to the model fitting. Similar to the conclusions by Gurka et al. (2011) 
and Verbeke and Molenberghs (2000) using other applications, the sandwich estimator is a valid alternative 
in GWAS when the model assumptions are misspecified, however it is less efficient than using the correct 
covariance model.
Similar to Jacqmin-Gadda et  al. (2007), we have shown that estimates of differences in slope by the 
number of copies of minor allele are sensitive to heterogeneous error variance particularly when the error 
variance depends on a covariate or increases over time. The variance of the estimates is underestimated and 
therefore the confidence interval is too narrow; this is consistent with the inflated type 1 error under these 
misspecified model assumptions.
Of all the misspecifications investigated, the situation where the error variance increases over time and 
is not accounted for in the modelling has poor parameter estimates, low power and the most inflation of the 
type 1 error, particularly for the SNP*age interaction terms. It also appears that by using the robust standard 
error, the inflation in the type 1 error is reduced to the nominal level in only some of the scenarios. It is there-
fore imperative that some adjustment is made in the modelling to account for this increasing variance over 
time. In the ALSPAC BMI data, the variance stays relatively constant until around the age of four years where 
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it rapidly increases until around 11 years of age where it plateaus again. This is due to the different growth 
rates between individuals through the adiposity rebound and puberty. Increasing variability over time can be 
seen with many other phenotypes both in childhood and adulthood; for example lung function in an elderly 
population can decrease due to the rate at which individuals are diagnosed with diseases such as chronic 
obstructive pulmonary disease, while other individuals remain healthy. Variance functions for modelling 
heteroscedasticity in mixed effects models have been studied in detail by Davidian and Giltinan (1995) and 
can be implemented using the varFunc classes in the nlme package in R (Pinheiro and Bates, 2000). There are 
also equivalent functions in alternative statistical packages such as MLwiN (Rasbash et al., 2012). The use of 
these variance functions could be recommended in the context of GWAS, if there is remaining heteroscedas-
ticity in the residuals after appropriately modelling the fixed and random effects; however further studies are 
needed to assess their properties in this context.
When looking at SNPs with low minor allele frequencies, we have seen that by using the robust standard 
error we reduce our power by approximately 5%. To counteract this reduction, we can increase the sample 
size though the use of meta-analysis of multiple cohort studies as is commonly done in GWAS analyses. 
However, several manuscripts have previously discussed the extended computational time for longitudinal 
GWAS in comparison to GWAS of cross-sectional phenotypes, so it is recommended that large computing 
clusters are available to those cohort studies conducting analyses. The longitudinal GWAS of cardiovascular 
risk factors presented in Smith et al. (2010) took approximately 3 h on 64 processors of a compute cluster 
for 600,000 tests in 525 individuals. Sikorska et al. (2013) illustrated that the analysis of 2.5 million SNPs 
using the LME function in the nlme package of R would take 3500 h for a sample size of 3000 individuals on 
a desktop computer (Intel(R) Core(TM) 2 Duo CPU, 3.00 GHz). These times are consistent with those in this 
study; the chromosome 16 analysis of 14,875 SNPs in the 7916 ALSPAC individuals took approximately 125 h 
on 32 processors of a compute cluster (BlueCrystal Phase 2 cluster with each node having four 2 × 2.8 GHz core 
processors and 8 GB of RAM).
It has been suggested that the genome-wide significance threshold be set at 5 × 10–8 (Dudbridge and 
Gusnanto, 2008; Risch and Merikangas, 1996). In addition, Duggal et al. (2008) established an appropriate 
p-value threshold based on the number of independent SNP tests in a GWAS. If study data is imputed against 
the HapMap CEU population, they suggest a threshold of p < 6.09 × 10–6 be used to select SNPs with suggestive 
evidence for follow-up. Many cross-sectional GWAS studies use thresholds around this, generally ranging 
from p < 5 × 10–6 (Speliotes et al., 2010) to p < 10–5 (Thorleifsson et al., 2009), to select SNPs for replication. In 
longitudinal genetic association studies, particularly those with complex, non-linear trajectories, controlling 
the type 1 error of the many parameters involving SNP effects, can be quite challenging. This would be the 
case when using for example smoothed spline functions and those functions could interact with the SNP 
effects. Providing robust standard errors in this context can be difficult. As an alternative, it may be plau-
sible to use genomic control procedures to reduce a possible inflation in the type 1 error for the parameters 
involving the SNP effects (Devlin and Roeder, 1999; Dadd et al., 2009). Genomic control is typically used in 
genetic association studies to account for the potential confounding due to cryptic relatedness, and makes 
the assumption that the inflation in type 1 error is constant across all markers in the genome; this is plausible 
in the context of cryptic relatedness as the inflation is due to the kinship coefficients which are unrelated to 
the individual loci, however in the context of LMM’s one would need to show that the inflation was uniform 
across the genome or genetic region of interest. Benke et al. (2013) suggested using a joint test of all SNP 
effects, similar to the global Wald test used in the current study, as an optimal way to control the type 1 error 
and increase power. However, caution needs to be applied when utilizing this method for complex traits, 
such as BMI trajectories over childhood, and a genome-wide significance threshold should only be used if 
there is no inflation detected in the type 1 error. Benke et al. (2013) used a trait with a linear decrease over time 
and low correlation between the intercept and slope parameters; in contrast, in this study we have a complex 
trajectory over time with high correlation between the intercept and slope parameters, which indicated that 
the joint test has inflated type 1 error and can only be reduced using a robust estimate in some scenarios.
In summary, based on our simulation results, we strongly suggest fitting the same function of age in the 
fixed and random effect to avoid inflation of the type 1 error of the SNP*age interaction terms. If this is not 
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possible due to convergence issues, then we suggest using a robust standard error for the SNP by age inter-
action terms to reduce the type 1 error inflation in GWAS, regardless of whether the error term of the model 
correctly follows the model assumptions or not. If no inflation in the type 1 error is detected for a particular 
parameter of interest, then the classical standard error should be used; for example, for the SNP main effect 
parameter in this study.
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